Paller Lab

Editorial: Women's sexual health in epidermal differentiation disorders: a call for action pubmed.ncbi.nlm.nih.gov/41695651/

With the possibility that measles is on the rise, we dermatologists need to be on the lookout for children (or adults) coming in with the measles morbilliform rash and a history that is suspicious for this highly contagious disease. AP healio.com/news/dermatolo…

This year’s meeting will take the place of PC Project’s IPCC Symposium, with the same depth of science and an expanded focus that reflects the evolving classification of these conditions as epidermal differentiation disorders. #raredisease #dermatology

IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD ajmc.com/view/ige-media… #atopicdermatitis #dermatology #biologics

Excited to see our #Ichthyosis community come together again! Saturday, January 17, 2026 Lurie Children’s Hospital, Chicago It’s a special chance to meet others living with Ichthyosis, hear updates on ongoing #research, and enjoy some fun and support together. #raredisease

We’re excited to see how this study could improve care for people with atopic dermatitis. #atopicdermatitis #eczema #dermatologyresearch

An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds #raredisease #epdermolysisbullosa #microbiome @ExpDermatol @NUFeinbergDerm pubmed.ncbi.nlm.nih.gov/40803690/

ajmc.com/view/ige-media… via @AJMC

New review article! Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase Inhibitors doi.org/10.1016/j.jaip… #atopicdermatitis #dermatology #biologics #jakinhibitors

New Treatments in Atopic Dermatitis Update #atopicdermatitis #dermatology pubmed.ncbi.nlm.nih.gov/40562170/

An international multicenter, retrospective cohort study of 203 patients with pediatric androgenetic #alopecia #dermatology #pediatricdermatology pubmed.ncbi.nlm.nih.gov/39921108/

Efficacy and Safety of Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3, a Phase 3, Randomized Double-Blind Study #atopicdermatitis #dermatology #pediatricdermatology pubmed.ncbi.nlm.nih.gov/40378883/

Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis #atopicdermatitis #dermatology #pediatricdermatology pubmed.ncbi.nlm.nih.gov/40126804/

New Review Alert: Deciding which patients with atopic dermatitis to prioritize for biologics and Janus kinase inhibitors #atopicdermatitis #biologics #jakinhibitors #dermatology #dermatologyresearch pubmed.ncbi.nlm.nih.gov/40368249/

FDA approves cell-sheet-based gene therapy for severe skin disease #raredisease #epidermolysisbullosa #dermatology #skinwound nature.com/articles/d4157…

Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa #rdeb #raredisease #epidermolysisbullosa #dermatology pubmed.ncbi.nlm.nih.gov/39790012/

Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa #raredisease #epidermolysisbullosa #dermatology pubmed.ncbi.nlm.nih.gov/40220208/

Having a device that can measure TEWL remotely, continuously or as programmed by the investigator - and without perturbing a patient during sleep - is a major advance. #wearabledevices A non-contact wearable device for monitoring epidermal molecular flux pubmed.ncbi.nlm.nih.gov/40205217/

Decision Aid for Pediatric Atopic Dermatitis #atopicdermatitis #pediatricdermatology #dermatology pubmed.ncbi.nlm.nih.gov/39921089/

A new classification of hereditary EDDs highlights shared disease mechanisms—unlocking targeted, pathogenesis-based treatments. From lovastatin-cholesterol to kallikrein inhibitors and gene editing, care for syndromic ichthyosis is evolving. doi.org/10.1093/bjd/lj… #raredisease